Multiple Sclerosis and Glutamate
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kerlero de Rosbo N., 1993, Reactivity to myelin antigens in multiple sclerosis, Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest., 92, 2602
Raine C.S., 1981, Multiple sclerosis, Oligodendrocyte survival and proliferation in an active established lesion. Lab. Invest., 45, 534
Linington C., 1988, Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein, Am. J. Pathol., 130, 443
Charcot M., 1868, Histologie de la sclerose en plaques, Gaz. Hosp., 141, 554
Clegg A., 2000, Disease‐modifying drugs for multiple sclerosis: a rapid and systematic review, Health Technol. Assess., 4, 1, 10.3310/hta4090
Paty D.W., 1993, Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis, II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNβ Multiple Sclerosis Study Group. Neurology, 43, 662
The IFNβ Multiple Sclerosis Study Group, 1993, Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis, I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology, 43, 655
Simon J.H., 2000, A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta‐1a, Multiple Sclerosis Collaborative Research Group. Neurology, 55, 185
Lassmann H. 1998. Pathology of multiple sclerosis.InMcAlpine's Multiple Sclerosis. A. Compston G. Ebers H. Lassmann et al. Eds.: 323‐358. Churchill Livingstone London.
Losseff N.A., 1998, Measures of brain and spinal cord atrophy in multiple sclerosis, J. Neurol. Neurosurg. Psychiatr., 64, S102
Shaw P.J. 1998. Excitotoxicity genetics and neurodegeneration in amyotrophic lateral sclerosis.InExcitatory Amino Acids: From Genes to Therapy. P.H. Seeburg I. Bresink & L. Turski Eds.: 65‐94. Springer Berlin.
Waksman B.H., 1959, Experimental allergic encephalomyelitis and the auto‐allergic diseases, Int. Arch. Allergy Appl. Immunol., 14, S1
Kojima K., 1997, Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100β, J. Neural. Transm., 49, S43
Simmons R.D., 1982, Experimental autoimmune encephalomyelitis, An anatomically-based explanation of clinical progression in rodents. J. Neuroimmunol., 3, 307
Schmied M., 1993, Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis, Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol., 143, 446
Bolton C., 1997, MK‐801 limits neurovascular dysfunction during experimental allergic encephalomyelitis, J. Pharmacol. Exp. Ther., 282, 397, 10.1016/S0022-3565(24)36794-1
Gong C., 2000, Inhibition of NAALADase protects neurons against glucose‐induced programmed cell death in models of diabetic neuropathy, Soc. Neurosci. (Abstr.), 26, 1135
Slusher B.S., 2000, NAALADase inhibition increases survival and delays clinical symptoms in an SOD transgenic model of ALS, Soc. Neurosci. Abstr., 26, 113
Wozniak K.M., 2000, NAALADase inhibition enhances behavioral and morphological recovery following sciatic nerve crush in mice, Soc. Neurosci. (Abstr.), 26, 1145
Tarnawa I., 1998, 2,3‐Benzodiazepine AMPA antagonists, Restor. Neurol. Neurosci., 13, 41
Paxinos G. & C. Watson. 1998. The Rat Brain in Stereotaxic Coordinates. Academic Press London.
Cruz‐Orive L.M., 1990, Recent stereological methods for cell biology: a brief survey, Am. J. Physiol., 258, L148
Mason D., 1990, The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat, Immunology, 70, 1
Tokarev D., 1997, Effect of central administration of the non‐NMDA receptor antagonist DNQX on ACTH and corticosterone release before and during immobilization stress, Meth. Find. Exp. Clin. Pharmacol., 19, 323
Kreutzberg G.W. W.F. Blakemore & M.B. Graeber. 1997. Cellular pathology of the central nervous system.InGreenfield's Neuropathology. D.I. Graham & P.L. Lantos Eds.: 85‐156. Arnold London.
Humble J.G., 1956, Biological interaction between lymphocytes and other cells, Brit. J. Hæmat., 2, 183, 10.1111/j.1365-2141.1956.tb06700.x
Hughes D., 1968, Invasion of neurones in vitro by non immune lymphocytes, An electron microscopic study. Brit. J. Exp. Pathol., 49, 356
Bauer J., 2001, Destruction of neurons by cytotoxic T cells in Rasmussen's encephalitis, J. Neuroimmunol., 118, A140
Roger R.C., 2000, TNF, glutamate and neurodegeneration in the rat spinal cord, Soc. Neurosci. (Abstr.), 26, 1186
Villaroya H., 1996, Myelin‐induced experimental autoimmune encephalomyelitis in Lewis rats: tumour necrosis factor α levels in serum and cerebrospinal fluid, Immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord. J. Neuroimmunol., 64, 55
Fine S.M., 1996, Tumor necrosis factor α inhibits glutamate uptake by primary human astrocytes, Implications for pathogenesis of HIV-1 dementia. J. Biol. Chem., 271, 15303